Physician profile
Roger Perilstein
NPI 1669495719
$1,631.37
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $485 · 2021: $13.49.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $357.19 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $281.71 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $259.40 | 2019-2020 | |
| Lundbeck LLC | $212.23 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $116.10 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $113.51 | 2019 | |
| Adlon Therapeutics L.P. | $75.62 | 2019-2020 | |
| Shire North American Group INC | $66.21 | 2019 | |
| Neos Therapeutics, LP | $51.87 | 2019-2020 | |
| Bausch Health US, LLC | $50.18 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $17.50 | 2019 | |
| Tris Pharma INC | $15.59 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Perilstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.